Lumenis Introduces Advanced SPLENDOR X™ Hair Removal Laser Technology with Promising Clinical Outcomes
Lumenis Be. Ltd., a leader in energy-based medical devices, recently made a significant announcement at the Annual American Society for Laser Medicine and Surgery (ASLMS) Conference in Orlando. The company unveiled an enhanced version of its acclaimed SPLENDOR X™ laser hair removal system, which incorporates advanced clinical data and superior technology designed to provide customized hair removal solutions for a diverse patient demographic.
The SPLENDOR X™ system is powered by Lumenis' pioneering BLEND X® technology, which features the only FDA-approved simultaneous dual-wavelength laser emission. Specifically, it combines Alexandrite (755 nm) and Nd:YAG (1064 nm) lasers, enabling practitioners to tailor treatments based on various skin tones and hair types. The clinical benefits of this innovative technology were evaluated in a comprehensive, multi-center study spanning 12 months, and the results are set to be presented during the ASLMS Conference.
Dr. Anne Chapas, an esteemed board-certified dermatologist and founder of Union Square Laser Dermatology, emphasized the importance of having versatile solutions for laser hair removal, stating, "As one of the clinical sites in the BLEND X® study, we’ve experienced firsthand the advantages of this technology, which allows for superior hair reduction while customizing treatment for each individual."
With the introduction of the new SPLENDOR X™, clinicians in the U.S. and Canada will benefit from a user-friendly design along with advanced digital functionalities that enhance system reliability and performance. Notably, the updated system includes preset parameters specifically designed for laser hair removal and vascular treatments, streamlining the process for practitioners.
Tzipi Ozer-Armon, CEO of Lumenis, expressed excitement about the launch, underscoring the company's ongoing commitment to innovation within the laser hair removal space. Ozer-Armon stated, "We are proud to lead the industry with our SPLENDOR X™ system, which not only meets but exceeds our goals of providing safe, effective, and comfortable treatments. The clinical evidence obtained through our innovative BLEND X® technology confirms our dedication to enhancing patients' confidence through results-driven solutions."
The clinical study results and enhanced functionalities of the SPLENDOR X™ will surely make a significant impact on practitioners' approaches to hair removal and aesthetic treatments. The technology’s ability to deliver custom-tailored solutions across numerous demographics reflects Lumenis' goal to continuously advance medical aesthetic technology.
Furthermore, the SPLENDOR X™ system is designed for optimum patient safety and comfort, featuring a Dual Cooling System (DCS) and an integrated plume evacuator, which not only streamlines the procedure but also creates a more pleasant experience for patients. This shift towards prioritizing both provider efficiency and patient comfort marks a new standard in laser hair removal practices.
In conclusion, Lumenis' SPLENDOR X™ is set to redefine the laser hair removal landscape by combining cutting-edge technology with proven clinical efficacy. With its recent introduction to the U.S. and Canadian markets, we anticipate that this innovative solution will significantly contribute to meeting the growing demand for effective laser hair removal treatments. For more information about the SPLENDOR X™ and BLEND X® technology, visit www.lumenis.com/splendorx.
The SPLENDOR X™ system is powered by Lumenis' pioneering BLEND X® technology, which features the only FDA-approved simultaneous dual-wavelength laser emission. Specifically, it combines Alexandrite (755 nm) and Nd:YAG (1064 nm) lasers, enabling practitioners to tailor treatments based on various skin tones and hair types. The clinical benefits of this innovative technology were evaluated in a comprehensive, multi-center study spanning 12 months, and the results are set to be presented during the ASLMS Conference.
Dr. Anne Chapas, an esteemed board-certified dermatologist and founder of Union Square Laser Dermatology, emphasized the importance of having versatile solutions for laser hair removal, stating, "As one of the clinical sites in the BLEND X® study, we’ve experienced firsthand the advantages of this technology, which allows for superior hair reduction while customizing treatment for each individual."
With the introduction of the new SPLENDOR X™, clinicians in the U.S. and Canada will benefit from a user-friendly design along with advanced digital functionalities that enhance system reliability and performance. Notably, the updated system includes preset parameters specifically designed for laser hair removal and vascular treatments, streamlining the process for practitioners.
Tzipi Ozer-Armon, CEO of Lumenis, expressed excitement about the launch, underscoring the company's ongoing commitment to innovation within the laser hair removal space. Ozer-Armon stated, "We are proud to lead the industry with our SPLENDOR X™ system, which not only meets but exceeds our goals of providing safe, effective, and comfortable treatments. The clinical evidence obtained through our innovative BLEND X® technology confirms our dedication to enhancing patients' confidence through results-driven solutions."
The clinical study results and enhanced functionalities of the SPLENDOR X™ will surely make a significant impact on practitioners' approaches to hair removal and aesthetic treatments. The technology’s ability to deliver custom-tailored solutions across numerous demographics reflects Lumenis' goal to continuously advance medical aesthetic technology.
Furthermore, the SPLENDOR X™ system is designed for optimum patient safety and comfort, featuring a Dual Cooling System (DCS) and an integrated plume evacuator, which not only streamlines the procedure but also creates a more pleasant experience for patients. This shift towards prioritizing both provider efficiency and patient comfort marks a new standard in laser hair removal practices.
In conclusion, Lumenis' SPLENDOR X™ is set to redefine the laser hair removal landscape by combining cutting-edge technology with proven clinical efficacy. With its recent introduction to the U.S. and Canadian markets, we anticipate that this innovative solution will significantly contribute to meeting the growing demand for effective laser hair removal treatments. For more information about the SPLENDOR X™ and BLEND X® technology, visit www.lumenis.com/splendorx.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.